Doximity (DOCS) Set to Announce Quarterly Earnings on Thursday

Doximity (NASDAQ:DOCS) is set to issue its quarterly earnings data after the market closes on Thursday, August 8th. Analysts expect the company to announce earnings of $0.22 per share for the quarter. Doximity has set its FY 2025 guidance at EPS and its Q1 2025 guidance at EPS.Investors that wish to listen to the company’s conference call can do so using this link.

Doximity (NASDAQ:DOCS) last announced its quarterly earnings results on Thursday, May 16th. The company reported $0.20 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.04. The business had revenue of $118.06 million for the quarter, compared to analysts’ expectations of $116.46 million. Doximity had a net margin of 31.04% and a return on equity of 17.44%. On average, analysts expect Doximity to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Doximity Stock Performance

Shares of DOCS opened at $26.24 on Wednesday. The firm has a market capitalization of $4.87 billion, a P/E ratio of 36.44, a P/E/G ratio of 5.12 and a beta of 1.22. Doximity has a 52 week low of $19.71 and a 52 week high of $34.56. The stock has a 50 day moving average price of $27.95 and a two-hundred day moving average price of $27.35.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on DOCS shares. Evercore ISI raised their price objective on Doximity from $28.00 to $29.00 and gave the company an “in-line” rating in a research note on Friday, May 17th. Wells Fargo & Company cut shares of Doximity from an “equal weight” rating to an “underweight” rating and cut their price target for the stock from $27.00 to $19.00 in a report on Thursday, July 18th. Morgan Stanley reissued an “underweight” rating and set a $25.00 target price on shares of Doximity in a research report on Tuesday, April 23rd. Needham & Company LLC restated a “hold” rating on shares of Doximity in a research note on Friday, May 17th. Finally, William Blair reaffirmed an “outperform” rating on shares of Doximity in a research report on Friday, May 17th. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $28.00.

Insider Activity

In related news, CFO Anna Bryson sold 30,000 shares of the business’s stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $30.00, for a total transaction of $900,000.00. Following the completion of the transaction, the chief financial officer now owns 288,685 shares of the company’s stock, valued at $8,660,550. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In other Doximity news, CFO Anna Bryson sold 30,000 shares of the company’s stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $30.00, for a total value of $900,000.00. Following the transaction, the chief financial officer now directly owns 288,685 shares in the company, valued at approximately $8,660,550. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Watkin Phoebe L. Yang sold 1,011 shares of the business’s stock in a transaction dated Monday, August 5th. The stock was sold at an average price of $25.54, for a total value of $25,820.94. Following the transaction, the director now directly owns 11,258 shares of the company’s stock, valued at approximately $287,529.32. The disclosure for this sale can be found here. Insiders have sold a total of 51,951 shares of company stock worth $1,524,843 over the last ninety days. Company insiders own 39.40% of the company’s stock.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.